Cargando…

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 2

Detalles Bibliográficos
Autor principal:	Bloomgarden, Zachary T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes Care Electronic Pages
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142029/ https://www.ncbi.nlm.nih.gov/pubmed/21788634 http://dx.doi.org/10.2337/dc11-0936

Ejemplares similares

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 3
por: Bloomgarden, Zachary T.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 4
por: Bloomgarden, Zachary T.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 1
por: Bloomgarden, Zachary T.
Publicado: (2011)

Diabetes and Cardiovascular Disease
por: Bloomgarden, Zachary T.
Publicado: (2011)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Diabetes Treatment and Cardiovascular Safety
por: Bloomgarden, Zachary T.
Publicado: (2011)

Insulin Concerns and Promises
por: Bloomgarden, Zachary T.
Publicado: (2011)

American Diabetes Association Postgraduate Meetings—2011
por: Bloomgarden, Zachary T.
Publicado: (2011)

Final “Perspectives on the News”: American Association of Clinical Endocrinology and American Diabetes Association 2011
por: Bloomgarden, Zachary T.
Publicado: (2011)

Nonnutritive Sweeteners, Fructose, and Other Aspects of Diet
por: Bloomgarden, Zachary T.
Publicado: (2011)

Association of Type B Insulin Resistance and Type 1 Diabetes Resulting in Ketoacidosis
por: Bourron, Olivier, et al.
Publicado: (2012)

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)

Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012)

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012)

A Case of Insulin-Dependent Diabetes Associated With Enteroviral Infections
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)

Insulin Edema in a Patient With Cystic Fibrosis–Related Diabetes
por: O'Neal, Katherine S., et al.
Publicado: (2012)

The Cardiovascular Relevance of Celiac Disease
por: Pitocco, Dario, et al.
Publicado: (2012)

Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Natarajan, Sabareesh, et al.
Publicado: (2012)

Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Calleja, Ana I., et al.
Publicado: (2012)

Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815
por: Koduru, Sobha Rani, et al.
Publicado: (2012)

Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815
por: Lassenius, Mariann I., et al.
Publicado: (2012)

Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog
por: Swelheim, Hester T., et al.
Publicado: (2012)

Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Tobar, Natália, et al.
Publicado: (2012)

Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Rossen, Niklas B., et al.
Publicado: (2011)

Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Ramos-Zavala, Maria G., et al.
Publicado: (2012)

Response to Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Hermida, Ramón C., et al.
Publicado: (2011)

Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Scaramuzza, Andrea E., et al.
Publicado: (2011)

Response to Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Luijf, Yoeri M., et al.
Publicado: (2011)

Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Kuhadiya, Nitesh D., et al.
Publicado: (2012)

Response to Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Lerchbaum, Elisabeth, et al.
Publicado: (2012)

Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial
por: Choi, Hyung Jin, et al.
Publicado: (2011)

Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Kramer, Caroline K., et al.
Publicado: (2011)

The world congress on insulin resistance, diabetes, and cardiovascular disease (WCIRDC)
por: Bloomgarden, Zachary
Publicado: (2022)

The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
por: Bloomgarden, Zachary T.
Publicado: (2023)

Response to Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Boronat, Mauro, et al.
Publicado: (2011)

Comment on: Morden et al. Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A Retrospective Cohort Study of Older Medicare Patients. Diabetes Care 2011;34:1965–1971
por: Badrick, Ellena L., et al.
Publicado: (2012)

Response to Comment on: Morden et al. Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A Retrospective Cohort Study of Older Medicare Patients. Diabetes Care 2011;34:1965–1971
por: Morden, Nancy E., et al.
Publicado: (2012)

Insulin Autoimmune Syndrome Induced by α–Lipoic Acid in a Caucasian Woman: Case Report
por: Bresciani, Enrico, et al.
Publicado: (2011)

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
por: Cavelti-Weder, Claudia, et al.
Publicado: (2011)

Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Sonmez, Alper, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7ni27dpin9gef4dmbp67ufn1u8